Skip to main content
. 2022 Jul 5;13:848586. doi: 10.3389/fimmu.2022.848586

Figure 5.

Figure 5

SARS-CoV-2-specific T cell response at baseline and two weeks after the second vaccine dose in healthy unexposed donors. SARS-CoV-2 specific T cells (CD4+ IFN-γ+ CD69+) after stimulation with spike and nucleocapsid SARS-CoV-2 peptide pools at baseline and two weeks after the second vaccine dose. Each dot represents an individual subject. *Statistical comparison at baseline and post-vaccination was performed with the Wilcoxon test.